Ambica Parmar
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 11, 2024
Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer.Ambica Parmar, Brandon Lu, Jin Luo
|Feb 06, 2024
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada.Grace K Grafham, Kenneth J Craddock, Weei-Yuarn Huang
|Dec 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.Ambica Parmar, Sunita Ghosh, Arjun Sahgal
|Mar 21, 2020
Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.Monica Shah, Ambica Parmar, Kelvin K W Chan
|Jan 09, 2020
Assessing the efficacy-effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population-based, real-world data for contemporary parenteral cancer therapeutics.Cameron M Phillips, Ambica Parmar, Helen Guo
|Nov 12, 2019
Value-based pricing: Toward achieving a balance between individual and population gains in health benefits.Ambica Parmar, Tina Jiao, Ronak Saluja
Pageof 2
